-
-
-
-
-
-
-
Amneal reports positive interim results for Parkinson's drug CREXONT
-
-
-
-
-
-
-
TTM Technologies, Dutch Bros among companies joining S&P MidCap 400; Others join S&P SmallCap 600
-
-
-
-
-
-
-
Amneal submits biosimilar application for XOLAIR to FDA
-
-
-
-
-
-
-
Key Takeaways from Virtual Generics & Biosimilars Day at UBS
-
-
-
-
-
-
-
Amneal Pharmaceuticals' (AMRX) BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c, provides guidance
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) and Shilpa Announce U.S. FDA Approval of BORUZU
-
456,181 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

